Syros Pharmaceuticals Stock Investor Sentiment

SYRS Stock  USD 0.27  0.02  8.00%   
Slightly above 56% of all Syros Pharmaceuticals' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Syros Pharmaceuticals suggests that some traders are interested. Syros Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Syros Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
over two months ago at businesswire.com         
Syros Pharmaceuticals, Inc. Investigation Bronstein, Gewirtz and Grossman, LLC Encourages Shareholde...
businesswire News
over two months ago at accesswire.com         
Syros Pharmaceuticals Inc. May Have Infringed On Shareholders Rights And Those With Losses Are Urged...
news
over two months ago at accesswire.com         
The Schall Law Firm Is Looking Into Whether Syros Pharmaceuticals Is Liable To Stockholders For Brea...
news
over three months ago at accesswire.com         
Syros Pharmaceuticals Being Investigated on Behalf of Syros Pharmaceuticals, Inc. Investors. Contact...
news
over three months ago at accesswire.com         
Disposition of 34837 shares by Richard Young of Syros Pharmaceuticals at 5.12 subject to Rule 16b-3
news
over three months ago at accesswire.com         
SYRS ALERT- Levi Korsinsky Has Commenced an Investigation on Behalf of Syros Pharmaceuticals, Inc. S...
news
over three months ago at accesswire.com         
Shareholders that lost money on Syros Pharmaceuticals, Inc. should contact Levi Korsinsky about Secu...
news
over three months ago at businesswire.com         
Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences
businesswire News
over three months ago at businesswire.com         
Syros Pharmaceuticals, Inc. Investigation Bronstein, Gewirtz and Grossman, LLC Encourages Shareholde...
businesswire News
over three months ago at businesswire.com         
Syros Pharmaceuticals, Inc. Investigation Bronstein, Gewirtz and Grossman, LLC Encourages Shareholde...
businesswire News
over three months ago at accesswire.com         
The Schall Law Firm Is Looking Into Syros Pharmaceuticals Incs Potential Violations Of Securities La...
news
over three months ago at accesswire.com         
A Securities Fraud Inquiry Has Been Opened Into Syros Pharmaceuticals Inc And The Schall Law Firm Wa...
news
over three months ago at accesswire.com         
ATTENTION SYRS SHAREHOLDERS Investors who lost money on Syros Pharmaceuticals, Inc. are urged to con...
news
over three months ago at accesswire.com         
Levi Korsinsky Reminds Syros Pharmaceuticals Investors of the Ongoing Investigation into Potential V...
news
over three months ago at accesswire.com         
Syros Pharmaceuticals Inc Is Being Investigated By The Schall Law Firm For Possible Violations Of Se...
news
Far too much social signal, news, headlines, and media speculation about Syros Pharmaceuticals that are available to investors today. That information is available publicly through Syros media outlets and privately through word of mouth or via Syros internal channels. However, regardless of the origin, that massive amount of Syros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Syros Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Syros Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Syros Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Syros Pharmaceuticals alpha.

Syros Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Syros Stock Analysis

When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.